logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12257254 B1

PDFFull Text
Date of Patent:
Mar. 25, 2025

Filed:

Mar. 01, 2022

Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent

Applicant:

Convalife (Shanghai) Co. Limited, Shanghai, CN;

Inventors:

Stephen Joseph Shuttleworth, Oxfordshire, GB;

Andrew David Whale, Oxfordshire, GB;

Assignee:

Convalife (Shanghai) Co. Limited, Shanghai, CN;

Attorney:

DLA Piper LLP (US)

Primary Examiner:

Sikarl A Witherspoon

Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/4184 (2006.01); A61K 31/51 (2006.01); A61K 31/519 (2006.01); A61K 31/5386 (2006.01); A61K 31/58 (2006.01); A61K 31/69 (2006.01); A61K 38/05 (2006.01); A61K 45/06 (2006.01); C07D 471/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/4184 (2013.01); A61K 31/519 (2013.01); A61K 31/5386 (2013.01); A61K 31/69 (2013.01); A61K 38/05 (2013.01); A61K 45/06 (2013.01);
Abstract

The invention relates to a pharmaceutical composition comprising a combination of a compound of formula (I) or a pharmaceutically acceptable salt thereof, and at least one second agent selected from the group consisting of signal transduction pathway inhibitors, tumour immunotherapeutics, agents inhibiting the BCL2 family of proteins, agents inhibiting Mcl-1, proteasome Inhibitors, poly (ADP-ribose) polymerase (PARP) Inhibitors, aromatase inhibitors, conventional cytotoxic agents or a miscellaneous agent selected from abiraterone, ARN-509 and MYC inhibitors.

Find Patent Forward Citations

Shuttleworth, Stephen. (2025). Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent (U.S. Patent No. 12257254). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12257254

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…